Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 242,623 |
|
|||||
| News | - | ||||||
| Day High | 1.09 | Low High |
|||||
| Day Low | 1.03 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| OptiNose Inc | OPTN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 3.85% | 1.08 | 14:30:31 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.05 | 1.03 | 1.09 | 1.04 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,833 | 242,623 | US$ 1.06 | US$ 256,440 | - | 0.80 - 2.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:30:44 | 100 | US$ 1.08 | USD |
OptiNose Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 121.66M | 112.65M | - | 70.99M | -35.48M | -0.32 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
OptiNose News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/06/2024 | 15:33 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/29/2024 | 14:32 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 5/20/2024 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/20/2024 | 13:33 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 5/17/2024 | 11:00 | GlobeNewswire Inc. | Optinose to Present at the H.C. Wainwright 2nd Annual.. |
| 5/14/2024 | 08:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/14/2024 | 06:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/14/2024 | 06:00 | GlobeNewswire Inc. | Optinose Reports First Quarter 2024 Financial Results and.. |
| 5/10/2024 | 13:56 | GlobeNewswire Inc. | Optinose Announces Reporting Date for First Quarter 2024.. |
| 5/09/2024 | 06:09 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 5/09/2024 | 06:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/09/2024 | 06:03 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OPTN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.09 | 1.11 | 1.03 | 1.07 | 336,652 | -0.01 | -0.92% |
| 1 Month | 1.14 | 1.33 | 1.03 | 1.16 | 589,192 | -0.06 | -5.26% |
| 3 Months | 1.91 | 2.10 | 0.80 | 1.17 | 1,228,109 | -0.83 | -43.46% |
| 6 Months | 1.23 | 2.10 | 0.80 | 1.24 | 762,235 | -0.15 | -12.20% |
| 1 Year | 1.15 | 2.10 | 0.80 | 1.23 | 610,481 | -0.07 | -6.09% |
| 3 Years | 3.30 | 4.30 | 0.80 | 1.78 | 393,778 | -2.22 | -67.27% |
| 5 Years | 6.62 | 11.66 | 0.80 | 3.14 | 379,982 | -5.54 | -83.69% |
OptiNose Description
| OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation delivery system, to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825. |
